Aberrant Splicing Burden Predicts Immune Infiltration and Prognosis in Head and Neck Squamous Cell Carcinomas

Ähnliche Einträge

• Sex‐Specific Survival and Treatment Delay in Oropharyngeal Squamous Cell Carcinoma
  von: Sandhya Kalavacherla, et al.
  Veröffentlicht: (2024)
• Prognosis After Discontinued Treatment due to Immune‐Related Adverse Events in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
  von: Hiromasa Ishihara, et al.
  Veröffentlicht: (2025)
• Risk Factors for Progressive Disease After Immune Checkpoint Inhibitor Therapy in Head and Neck Squamous Cell Carcinoma
  von: Seo Yoon Jang, et al.
  Veröffentlicht: (2025)
• The Burden of Recurrent Head and Neck Squamous Cell Carcinoma Across the United Kingdom: Results From a National Snapshot Study
  von: Andrew Williamson, et al.
  Veröffentlicht: (2024)
• Association of Socioeconomic Factors and Immunotherapy in Cutaneous Squamous Cell Carcinoma of the Head and Neck
  von: Christie Hung, et al.
  Veröffentlicht: (2026)